Pharmaceutical Technology Europe
The different pathways to regulatory approval of a biosimilar vary worldwide, ranging from no pathways at all in some developing countries, to the complex and precise mechanism that exists in Europe.
Peter Wittner
Advertisement
Peter Wittner is an independent consultant.
Articles by Peter Wittner
Advertisement
Latest Updated Articles
- Biosimilars: Is It Worth Taking On The Regulators?
August 1st 2010
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5